DL-Leucine

Details

Top
Internal ID 63f15178-e00c-4d9f-aeda-a881691ba582
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Leucine and derivatives
IUPAC Name 2-amino-4-methylpentanoic acid
SMILES (Canonical) CC(C)CC(C(=O)O)N
SMILES (Isomeric) CC(C)CC(C(=O)O)N
InChI InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)
InChI Key ROHFNLRQFUQHCH-UHFFFAOYSA-N
Popularity 2,341 references in papers

Physical and Chemical Properties

Top
Molecular Formula C6H13NO2
Molecular Weight 131.17 g/mol
Exact Mass 131.094628657 g/mol
Topological Polar Surface Area (TPSA) 63.30 Ų
XlogP -1.50
Atomic LogP (AlogP) 0.44
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
328-39-2
H-DL-Leu-OH
2-Amino-4-methylpentanoic acid
Leucine, DL-
(RS)-Leucine
(+-)-Leucine
25322-63-8
MFCD00063087
2-amino-4-methyl-pentanoic acid
NSC46709
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of DL-Leucine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9950 99.50%
Caco-2 - 0.9372 93.72%
Blood Brain Barrier + 0.7250 72.50%
Human oral bioavailability + 0.7286 72.86%
Subcellular localzation Lysosomes 0.7172 71.72%
OATP2B1 inhibitior - 0.8277 82.77%
OATP1B1 inhibitior + 0.9631 96.31%
OATP1B3 inhibitior + 0.9448 94.48%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9238 92.38%
P-glycoprotein inhibitior - 0.9792 97.92%
P-glycoprotein substrate - 0.9590 95.90%
CYP3A4 substrate - 0.7943 79.43%
CYP2C9 substrate + 0.6453 64.53%
CYP2D6 substrate - 0.8051 80.51%
CYP3A4 inhibition - 0.9558 95.58%
CYP2C9 inhibition - 0.9543 95.43%
CYP2C19 inhibition - 0.9608 96.08%
CYP2D6 inhibition - 0.9336 93.36%
CYP1A2 inhibition - 0.9045 90.45%
CYP2C8 inhibition - 0.9953 99.53%
CYP inhibitory promiscuity - 0.9910 99.10%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6200 62.00%
Carcinogenicity (trinary) Non-required 0.6822 68.22%
Eye corrosion - 0.9168 91.68%
Eye irritation - 0.5276 52.76%
Skin irritation - 0.6725 67.25%
Skin corrosion + 0.6386 63.86%
Ames mutagenesis - 0.8800 88.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8642 86.42%
Micronuclear - 0.5000 50.00%
Hepatotoxicity + 0.7500 75.00%
skin sensitisation - 0.9234 92.34%
Respiratory toxicity - 0.6222 62.22%
Reproductive toxicity - 0.6354 63.54%
Mitochondrial toxicity - 0.6000 60.00%
Nephrotoxicity - 0.7927 79.27%
Acute Oral Toxicity (c) III 0.6794 67.94%
Estrogen receptor binding - 0.9094 90.94%
Androgen receptor binding - 0.8427 84.27%
Thyroid receptor binding - 0.8943 89.43%
Glucocorticoid receptor binding - 0.9093 90.93%
Aromatase binding - 0.8905 89.05%
PPAR gamma - 0.8448 84.48%
Honey bee toxicity - 0.9876 98.76%
Biodegradation + 0.8250 82.50%
Crustacea aquatic toxicity - 0.9200 92.00%
Fish aquatic toxicity - 0.7543 75.43%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293235 P02545 Prelamin-A/C 501.2 nM
Potency
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.01% 96.09%
CHEMBL2581 P07339 Cathepsin D 92.15% 98.95%
CHEMBL221 P23219 Cyclooxygenase-1 92.01% 90.17%
CHEMBL3976 Q9UHL4 Dipeptidyl peptidase II 91.40% 92.29%
CHEMBL4040 P28482 MAP kinase ERK2 87.95% 83.82%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 87.21% 96.47%
CHEMBL3359 P21462 Formyl peptide receptor 1 86.12% 93.56%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 85.13% 96.95%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 83.88% 100.00%
CHEMBL1907 P15144 Aminopeptidase N 82.07% 93.31%
CHEMBL3060 Q9Y345 Glycine transporter 2 81.15% 99.17%

Plants that contains it

Top

Cross-Links

Top
PubChem 857
LOTUS LTS0102123
wikiData Q60662890